Cite
HARVARD Citation
Tanaka, K. et al. (2022). Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation. BMJ open. 12 (5), p. . [Online].